Physician profile
Brigitte A Smith
NPI 1528724549
$1,986.02
in general payments reported to CMS, 2019-2025
15 companies · $665 in 2025
The $665 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,321 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.07 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $339.94 | 2024-2025 | Bimzelx |
| Genzyme Corporation | $297.87 | 2024 | |
| Incyte Corporation | $294.10 | 2024-2025 | Opzelura, Opzelura |
| Abbvie INC. | $159.78 | 2024-2025 | |
| Pfizer INC. | $157.93 | 2025 | |
| Novartis Pharmaceuticals Corporation | $122.09 | 2024-2025 | |
| Galderma Laboratories, L.P. | $119.59 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $97.47 | 2024-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $84.51 | 2024 | Sotyktu |
| Lilly USA, LLC | $82.41 | 2024 | Taltz, Ebglyss, Olumiant |
| Journey Medical Corporation | $67.88 | 2025 | |
| Sun Pharmaceutical Industries INC. | $66.77 | 2024 | |
| Amgen INC. | $50.00 | 2024 | Otezla |
| Janssen Biotech, INC. | $22.92 | 2024 | Tremfya |
| Leo Pharma INC. | $22.76 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigitte Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.